The RESI Conference (Redefining Early-stage Investments) kicked off the day before BIO. Our beleaguered Life Science Nation staff participated in the BIO International Convention, sharing some of their highlights:
Berlin Bayer Night at the ICA
Knobbes Martens Reception
J&J Innovation Partner Reception
PAB-NAB
McDermott, Will & Emery Beach Bash
Like BIO, we will be host another RESI Conference alongside the annual J.P. Morgan Healthcare Conference in January 2019! Registration is now open, hope to see you in San Francisco.
Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | Chris Chen, Business Development, TRWR | Ann Chiu, COO, TRWR | Kuo-Chuan Huang, Doctor, TRWR
On June 4th at the RESI Conference (Redefining Early-stage Investments), 30 Innovation Challenge Finalists competed for 1st, 2nd, and 3rd Prize: free tickets to a future RESI Conference. They competed directly on merits of innovation and commercial viability. We wish all our finalists the best in bringing their products to commercialization. Read More to learn about the winners!
Life Science Investor Mandates
